Skip to content
Longterm Wiki
Index
Grant·o73ICzM4Fz·Record·Profile

Grant: Nigerian Institute of Medical Research – COVID-19 Fractional Dosing Trial (Coefficient Giving → Nigerian Institute of Medical Research)

Verdictconfirmed95%
1 check · 4/9/2026

Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Our claim

entire record
Name
Nigerian Institute of Medical Research – COVID-19 Fractional Dosing Trial
Amount
$2,921,000
Currency
USD
Date
January 2022
Notes
[Biosecurity & Pandemic Preparedness] Open Philanthropy recommended a grant of $2,921,000 to the Nigerian Institute of Medical Research to support a safety and immunogenicity trial in adults in Nigeria of fractional doses of the AstraZeneca, Pfizer, and Johnson & Johnson COVID-19expand[Biosecurity & Pandemic Preparedness] Open Philanthropy recommended a grant of $2,921,000 to the Nigerian Institute of Medical Research to support a safety and immunogenicity trial in adults in Nigeria of fractional doses of the AstraZeneca, Pfizer, and Johnson & Johnson COVID-19 vaccines. The trial has the potential to indicate that smaller doses of these vaccines promote immune responses that are "non-inferior" to those from standard doses. If non-inferiority can be established, this could allow many people to be vaccinated against COVID-19 sooner despite limited supplies, and potentially affect booster recommendations in Nigeria or elsewhere, reducing deaths and other harms from the pandemic. This falls within our work on scientific research, and specifically within our interest in science supporting biosecurity and pandemic preparedness.

Source evidence

1 src · 1 check
confirmed95%deterministic-row-match · 4/9/2026
Name
Nigerian Institute of Medical Research – COVID-19 Fractional Dosing Trial
Grantee
Nigerian Institute of Medical Research
Focus Area
Biosecurity & Pandemic Preparedness
Amount
$2,92

NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Case № o73ICzM4FzFiled 4/9/2026Confidence 95%